References
- Smith TW: Drug therapy: digitalis glycosides. N Engl J Med 288:719–722, 942–946. 1973
- Smith TW, Haber E: Digitalis. N Engl J Med 289:945–952, 1010–1015, 1063–1072, 1125–1129, 1973
- Cohn JN: Indications for digitalis therapy: a new look. JAMA 229:1911–1914, 1974
- Greenblatt DJ, Smith TW, Koch-Weser J: Bioavailability of drugs: the digoxin dilemma. Clin Pharmacokin (in press)
- Greenblatt DJ, Duhme DW, Koch-Weser J, et al: Evaluation of digoxin bioavailability in single-dose studies. N Engl J Med 289:651–654, 1973
- Steiness E, Svendsen O, Rasmussen F: Plasma digoxin after parenteral administration: local reaction after intramuscular injection. Clin Pharmacol Ther 16:430–434, 1974
- Koup JR, Greenblatt DJ, Jusko WJ, etal: Pharmacokinetics of digoxin in normal subjects after intravenous bolus and infusion doses. J Pharmacokin et Biopharm 3:181–192, 1975
- Nyberg L, Andersson K-E, Bertler A: Bioavailability of digoxin from tablets. II. Radioimmunoassay and disposition pharmacokinetics of digoxin after intravenous administration. Acta Pharm Suec 11:459–470, 1974
- Doherty JE, Perkins WH, Flanigan WJ: The distribution and concentration of tritiated digoxin in human tissues. Ann Intern Med 66:116–124, 1967
- Coltart J, Howard M, Chamberlain D: Myocardial and skeletal muscle concentrations of digoxin in patients on long-term therapy. Br Med J 2:318–319, 1972
- Carroll PR. Gelbart A, O'Rourke MF, et al: Digoxin concentrations in the serum and myocardium of digitalised patients. Aust NZ J Med 3:400–403, 1973
- Gullner H-G, Stinson EB, Harrison DC, et al: Correlation of serum concentrations with heart concentrations of digoxin in human subjects. Circulation 50:653–655, 1974
- Karjalainen J. Ojala K, Reissell P: Tissue concentrations of digoxin in an autopsy material. Acta Pharmacol Toxicol 34:385–390, 1974
- Reuning RH. Sams RA, Notari RE: Role of pharmacokinetics in drug dosage adjustment. I. Pharmacologic effect kinetics and apparent volume of distribution of digoxin. J Clin Pharmacol 13:127–141, 1973
- Jusko WJ, Weintraub M: Myocardial distribution of digoxin and renal function. Clin Pharmacol Ther 16:449–454, 1974
- Huffman DH, Manion CV, Azarnoff DL: Intersubject variation in absorption of digoxin in normal volunteers. J Pharm Sci 64:433–437, 1975
- Johnson BF, Bye C: Maximal intestinal absorption of digoxin, and its relation to steady state plasma concentration. Br Heart J 37:203–208, 1975
- Watson E, Clark DR, Kalman SM: Identification by gas chromatography-mass spectroscopy of dihydrodigoxin—a metabolite of digoxin in man. J Pharmacol Exp Ther 184:424–431, 1973
- Clark DR, Kaiman SM: Dihydrodigoxin: a common metabolite of digoxin in man. Drug Metab Dispos 2:148–150, 1974
- Greenwood H, Snedden W, Hayward RP, et al: The measurement of urinary digoxin and dihydrodigoxin by radioimmunoassay and by mass spectroscopy. Clin Chim Acta 62:213–224, 1975
- Clayton BD: Reduction of digitalis glycoside intoxication by rational dosing procedures. Am J Hosp Pharm 31:855–865, 1974
- Sheiner LB, Melmon KL, Rosenberg B: Instructional goals for physicians in the use of blood level data—and the contribution of computers. Clin Pharmacol Ther 16:260–271, 1974
- Jelliffe RW, Buell J, Kalaba R: Reduction of digitalis toxicity by computer-assisted glycoside dosage regimens. Ann Intern Med 77:891–906, 1972
- Peck CC, Sheiner LB, Martin CM, et al: Computer-assisted digoxin therapy. N Engl J Med 289:441–446, 1973
- Wagner JG, Yates JD, Willis PW III, et al: Correlation of plasma levels of digoxin in cardiac patients with dose and measures of renal function. Clin Pharmacol Ther 15:291–301, 1974
- Duhme DW, Greenblatt DJ, Koch-Weser J: Reduction of digoxin toxicity associated with measurement of serum levels: a report from the Boston Collaborative Drug Surveillance Program. Ann Intern Med 80:516–519, 1974
- Koch-Weser J, Duhme DW, Greenblatt DJ: Influence of serum digoxin concentration measurements on frequency of digitoxicity. Clin Pharmacol Ther 16:284–287, 1974
- Rubin IL, Arbeit SR, Gross H: Diuretics versus digitalis in the treatment of congestive heart failure. J Clin Pharmacol 12:121–122, 1972
- Greenblatt DJ, Shader RI: Digitalis toxicity. In Shader RI (Editor): Psychiatric Complications of Medical Drugs, New York, Raven Press, 1972, pp 25–47
- Lely AH, Enter Chvan: Non-cardiac symptoms of digitalis intoxication. Am Heart J 83:149–152, 1972
- Gillis RA, Pearle DL, Levitt B: Digitalis: a neuroexcitatory drug. Circulation 52:739–742, 1975
- Garan H, Smith TW, Powell WJ Jr: The central nervous system as a site of action for the coronary vasoconstrictor effect of digoxin. J Clin Invest 54:1365–1372, 1974